Latest Articles
Robert Irwin Praises 'Amazing' Sister Bindi for Sharing Her Endometriosis Journey: 'I'm a Very Proud Brother' (Exclusive) - AOL.com
Robert Irwin Praises 'Amazing' Sister Bindi for Sharing Her Endometriosis Journey: 'I'm a Very Proud Brother' (Exclusive) AOL.com
Published: May 19, 2026, 8:57 a.m.
Bindi Irwin Shares Vulnerable Health Update: "Slowly Gaining My Strength Back" - MSN
Bindi Irwin Shares Vulnerable Health Update: "Slowly Gaining My Strength Back" MSN
Published: May 19, 2026, 5:09 a.m.
Woman told period pain was 'all in her head' made 30 A&E visits before diagnosis - Yorkshire Live
Woman told period pain was 'all in her head' made 30 A&E visits before diagnosis Yorkshire Live
Published: May 19, 2026, 3 a.m.
Professor Avery’s AI research reveals 20% have undiagnosed endometriosis - Daily Telegraph Sydney
Professor Avery’s AI research reveals 20% have undiagnosed endometriosis Daily Telegraph Sydney
Published: May 19, 2026, 2:34 a.m.
BBC star left on floor in intense pain as she shares reality of debilitating condition - MSN
BBC star left on floor in intense pain as she shares reality of debilitating condition MSN
Published: May 18, 2026, 11:05 p.m.
Professor Avery’s AI research reveals 20% have undiagnosed endometriosis - The Weekly Times
Professor Avery’s AI research reveals 20% have undiagnosed endometriosis The Weekly Times
Published: May 18, 2026, 9:17 p.m.
Professor Avery’s AI research reveals 20% have undiagnosed endometriosis - Adelaide Now
Professor Avery’s AI research reveals 20% have undiagnosed endometriosis Adelaide Now
Published: May 18, 2026, 5:52 p.m.
Professor Avery’s AI research reveals 20% have undiagnosed endometriosis - Herald Sun
Professor Avery’s AI research reveals 20% have undiagnosed endometriosis Herald Sun
Published: May 18, 2026, 3:08 p.m.
Easing pain: Way to slash endometriosis diagnosis by years - NT News
Easing pain: Way to slash endometriosis diagnosis by years NT News
Published: May 18, 2026, 2:19 p.m.
Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer - Business Wire
Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer Business Wire
Published: May 18, 2026, 10:45 a.m.
Link copied to clipboard!